Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
CONCLUSIONS: This real-world evidence suggests that clinical outcomes may vary among initiators of commonly used antidepressants in older adults, which may inform benefit-risk evaluation at treatment initiation, and highlights the importance of careful selection of antidepressant treatment.PMID:37849303 | DOI:10.1176/appi.ajp.20230356 (Source: The American Journal of Psychiatry)
Source: The American Journal of Psychiatry - October 18, 2023 Category: Psychiatry Authors: Kazi Ishtiak-Ahmed Katherine L Musliner Kaj Sparle Christensen Erik Lykke Mortensen Andrew A Nierenberg Christiane Gasse Source Type: research
Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-...
Source: Drug Metabolism Reviews - October 18, 2023 Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
CONCLUSIONS: This real-world evidence suggests that clinical outcomes may vary among initiators of commonly used antidepressants in older adults, which may inform benefit-risk evaluation at treatment initiation, and highlights the importance of careful selection of antidepressant treatment.PMID:37849303 | DOI:10.1176/appi.ajp.20230356 (Source: The American Journal of Psychiatry)
Source: The American Journal of Psychiatry - October 18, 2023 Category: Psychiatry Authors: Kazi Ishtiak-Ahmed Katherine L Musliner Kaj Sparle Christensen Erik Lykke Mortensen Andrew A Nierenberg Christiane Gasse Source Type: research
Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-...
Source: Drug Metabolism Reviews - October 18, 2023 Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
CONCLUSIONS: This real-world evidence suggests that clinical outcomes may vary among initiators of commonly used antidepressants in older adults, which may inform benefit-risk evaluation at treatment initiation, and highlights the importance of careful selection of antidepressant treatment.PMID:37849303 | DOI:10.1176/appi.ajp.20230356 (Source: The American Journal of Psychiatry)
Source: The American Journal of Psychiatry - October 18, 2023 Category: Psychiatry Authors: Kazi Ishtiak-Ahmed Katherine L Musliner Kaj Sparle Christensen Erik Lykke Mortensen Andrew A Nierenberg Christiane Gasse Source Type: research
Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-...
Source: Drug Metabolism Reviews - October 18, 2023 Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark
CONCLUSIONS: This real-world evidence suggests that clinical outcomes may vary among initiators of commonly used antidepressants in older adults, which may inform benefit-risk evaluation at treatment initiation, and highlights the importance of careful selection of antidepressant treatment.PMID:37849303 | DOI:10.1176/appi.ajp.20230356 (Source: The American Journal of Psychiatry)
Source: The American Journal of Psychiatry - October 18, 2023 Category: Psychiatry Authors: Kazi Ishtiak-Ahmed Katherine L Musliner Kaj Sparle Christensen Erik Lykke Mortensen Andrew A Nierenberg Christiane Gasse Source Type: research
Clinical pharmacokinetics of nebivolol: a systematic review
Drug Metab Rev. 2023 Nov;55(4):428-440. doi: 10.1080/03602532.2023.2271195. Epub 2023 Oct 28.ABSTRACTNebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus. This review investigated the data regarding pharmacokinetic (PK) parameters, drug-drug interactions, dextrorotatory (D), and levorotatory (L) stereoisomers of nebivolol. The articles related to the PK of nebivolol were retrieved by searching the five databases; Google Scholar, PubMed, Cochrane Library, ScienceDirect, and EBSCO. A total of 20 studies comprising plasma concentration-...
Source: Drug Metabolism Reviews - October 18, 2023 Category: Drugs & Pharmacology Authors: Nida Hanif Ammara Zamir Imran Imran Hamid Saeed Abdul Majeed Anees Ur Rehman Waseem Ashraf Faleh Alqahtani Muhammad Fawad Rasool Source Type: research
